HUANG J, YOU H, SU C, et al.Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates cGAS/STING-Mediated Antiviral Innate Immunity [J]. J Virol, 2018, 92(15).[J].J Virol, 2018, 92(15):e00841-18.-e00841-18. [2]JOHNSON N.First-ever HSV-1 recurrence following superficial facial chemical peel after 30-year latency following neonatal primary infection [J]. J Cosmet Dermatol, 2019.[J].J Cosmet Dermatol, 2019, 52(14):854-856 [3]KONDEL R, SHAFIQ N, KAUR I P, et al.Effect of acyclovir solid lipid nanoparticles for treatment of Herpes Simplex Virus (HSV) infection in an animal model of HSV-1 infection [J]. Pharm Nanotechnol, 2019.[J].Pharm Nanotechnol, 2019, :- [4]SU C, ZHENG C.Herpes Simplex Virus 1 Abrogates the cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway via Its Virion Host Shutoff Protein, UL41 [J]. J Virol, 2017, 91(6).[J].J Virol, 2017, 91(6):e02414-e02416 [5]LI D, SWAMINATHAN S.Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system[J].PLoS Pathog, 2019, 15(2):e1007609-e1007609 [6]MEARS H V, SWEENEY T R.Better together: the role of IFIT protein-protein interactions in the antiviral response[J].J Gen Virol, 2018, 99(11):1463-77 [7]JIANG Z, SU C, ZHENG C.Herpes Simplex Virus 1 Tegument Protein UL41 Counteracts IFIT3 Antiviral Innate Immunity[J].J Virol, 2016, 90(24):11056-61 [8]SU C, ZHAN G, ZHENG C.Evasion of host antiviral innate immunity by HSV-1, an update [J]. Virol J, 2016, 13(38).[J].Virol J, 2016, 13(38):- [9]SUN C, LUECKE S, BODDA C, et al.Cellular Requirements for Sensing and Elimination of Incoming HSV-1 DNA and Capsids[J].J Interferon Cytokine Res, 2019, 39(4):191-204 [10]SHEN G, WANG K, WANG S, et al.Herpes simplex virus 1 counteracts viperin via its virion host shutoff protein UL41[J].J Virol, 2014, 88(20):12163-6 [11]Ní GABHANN-DROMGOOLE J.Systemic IL-1β production as a consequence of corneal HSV-1 infection-contribution to the development of herpes simplex keratitis[J].International Journal of Ophthalmology, 2019, 12(9):1493-7 [12]MCFARLANE S, ORR A, ROBERTS A P E, et al.The histone chaperone HIRA promotes the induction of host innate immune defences in response to HSV-1 infection[J].PLoS Pathog, 2019, 15(3):e1007667-e1007667 [13]TADDEO B, ROIZMAN B.The virion host shutoff protein (UL41) of herpes simplex virus 1 is an endoribonuclease with a substrate specificity similar to that of RNase A[J].J Virol, 2006, 80(18):9341-5 [14]MEARS H V, EMMOTT E, CHAUDHRY Y, et al.Ifit1 regulates norovirus infection and enhances the interferon response in murine macrophage-like cells [J]. Wellcome Open Res, 2019, 4:82.[J].Wellcome Open Res,, 2019, 4(82):152-156 [15]MEHMOOD A, KAUSHIK A C, WEI D Q.Prediction and validation of potent peptides against herpes simplex virus type 1 via immunoinformatic and systems biology approach [J]. Chem Biol Drug Des, 2019.[J].Chem Biol Drug Des,, 2019, 36(45):e0254-e0254 [16]ZENNER H L, MAURICIO R, BANTING G, et al.Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity[J].J Virol, 2013, 87(24):13115-23 [17]WAISNER H, KALAMVOKI M.The ICP0 protein of herpes simplex virus 1 (HSV-1) down-regulates major autophagy adaptor proteins, sequestosome 1 (SQSTM1/p62) and optineurin (OPTN), during the early stages of HSV-1 infection [J]. J Virol, 2019.[J].J Virol,, 2019, 52(13):e0254-e0254 [18]ZHANG J, CHEN L, ZHANG J, et al.Drug Inducible CRISPR/Cas Systems [J]. Comput Struct Biotechnol J, 2019, 17:1171-7.[J].Comput Struct Biotechnol, 2019, 17:1171-1177 [19]YANG X, ZHANG X, FU M L, et al.Targeting the tumor microenvironment with interferon-beta bridges innate and adaptive immune responses[J].Cancer Cell, 2014, 25(1):37-48 [20]DRAPPIER M, MICHIELS T.Inhibition of the OAS/RNase L pathway by viruses [J]. Curr Opin Virol, 2015, 15:19-26.[J].Curr Opin Virol, 2015, 15:19-26
